21 January 2016

Proparco invests in CIEL Healthcare

Proparco has established a partnership with the Mauritian group CIEL to develop a chain of private hospitals in Sub-Saharan Africa.

The funds provided to the newly constituted subsidiary CIEL Healthcare Limited (CHL) will contribute to the acquisition of health facilities in the region and to the development of new leading-edge medical services in them (obstetrics, oncology, cardiology, etc.) which are not readily available locally. PROPARCO holds c.15% of CHL after this first capital round, alongside the sponsor CIEL and International Finance Corporation.

Two successful hospital acquisitions
CHL has already begun to build its health network by taking over Fortis Clinique Darné (FCD) in Mauritius  and International Medical Group  in Uganda. These facilities have benefited from a transfer of expertise and advanced medical technologies by Fortis Healthcare Ltd, India’s leader in hospital management, which is under contract with CHL. Since the takeover, FCD has renewed most of its units, introduced new specialties and strengthened its capacity. A primary healthcare center has also recently been opened in the north of the country. The International Hospital Kampala, for its part, has developed its specialties in obstetrics, surgery and intensive care, and upgraded existing facilities. A first national cancer treatment center is expected to be built soon.

Improving healthcare quality in African hospitals
Ciel Healthcare Limited will take majority stakes in leading hospitals and in a few smaller facilities. In each target country, CHL’s objective is to build integrated healthcare provision of a quality in line with the highest international standards. Fortis Healthcare will be responsible for developing and upgrading services.

Strengthening the hospital sector in Sub-Saharan Africa
CHL will contribute to developing health facilities in Sub-Saharan Africa, where healthcare provision is structurally deficient. By 2020, it is expected to create around a hundred additional beds, which will provide a capacity of 150,000 more patients. More generally, this operation will contribute to structuring the sector in Sub-Saharan Africa, where chronic underinvestment by governments means the private sector plays a role crucial in addressing the strong growth in healthcare demand.

CIEL Healthcare Limited (“CHL”) is a Mauritian registered private limited company, with a prime objective to own, operate and manage assets in the healthcare sector in Mauritius and across Sub-Saharan Africa (‘SSA’). CHL currently holds investments in The Medical and Surgical Centre Limited (‘MSCL’), which owns ‘Fortis Clinique Darné, the leading private hospital in Mauritius, The International Medical Group (‘IMG’), largest provider of private healthcare services in Uganda, The Laboratoire International de Bio Analyses Ltée (‘LIBA’), and CIEL Healthcare Africa Limited, healthcare management company.  Source: Press Release